Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polfa Pabianice, officially known as Zakłady Farmaceutyczne Polfa w Pabianicach, is a long-standing Polish pharmaceutical manufacturer headquartered in Pabianice. Founded in 1889 and later becoming part of the state-owned Polfa union, the company was acquired by the Adamed Group in 2010, integrating it into one of Poland's largest life sciences entities. The company specializes in the development and large-scale production of generic prescription (Rx) and over-the-counter (OTC) medicines across diverse therapeutic areas including cardiology, psychiatry, and pulmonology. Polfa Pabianice operates advanced manufacturing facilities that comply with global Good Manufacturing Practice (GMP) standards, serving both domestic and international markets. Its portfolio features well-recognized brands such as Polprazol and Metformax, reinforcing its role as a critical supplier of essential medicines in Central and Eastern Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polfa Pabianice.